West Pharmaceutical Services | WST - Sales Revenues

Stock Price
296.93
Daily Change
-5.27 -1.74%
Monthly
21.13%
Yearly
37.39%
Q2 Forecast
299.61

West Pharmaceutical Services reported $844.9M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Align Technology USD 1.05B 54.3M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
Dentsply International USD 961M 57M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
ICU Medical USD 540.7M 3.7M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 724M 24M Dec/2025
Repligen USD 197.91M 8.91M Dec/2025
Rockwell Medical USD 25.83M 3.15M Jun/2024
Solventum Corp USD 1.99B 110M Dec/2025
STAAR Surgical USD 239.4M 144.7M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Utah Medical Products USD 9.04M 955K Dec/2025
West Pharmaceutical Services USD 844.9M 39.9M Mar/2026